Immunoreactivity with the Anti-MAGE Antibody 57B in Malignant Melanoma: Frequency of Expression and Correlation with Prognostic Parameters
- 1 April 2000
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 13 (4) , 459-465
- https://doi.org/10.1038/modpathol.3880078
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Cancer Tumor antigensCurrent Opinion in Immunology, 1997
- Human tumor antigens recognized by T lymphocytes.The Journal of Experimental Medicine, 1996
- Expression of MAGE genes in primary and metastatic cutaneous melanomaInternational Journal of Cancer, 1995
- A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma.The Journal of Experimental Medicine, 1995
- Genes Coding for Tumor Antigens Recognized by Cytolytic T LymphocytesImmunological Reviews, 1995
- A peptide encoded by human gene MAGE‐3 and presented by HLA‐A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE‐3European Journal of Immunology, 1994
- Structure, chromosomal localization, and expression of 12 genes of the MAGE familyImmunogenetics, 1994
- Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes.The Journal of Experimental Medicine, 1994
- Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytesImmunogenetics, 1992
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991